Information has come forward recently from several sources which provides new insights into the mechanisms that underlie the haemodynamic responses to acute blood loss. In unanaesthetised animals and human volunteers there are two distinct phases to these responses. At first, the engagement of baroreflexes results in a progressive rise in sympathetic vasoconstrictor drive and peripheral resistance, and the maintenance of arterial blood pressure at a near-normal level. When about one-third of blood volume has been lost, reflex sympathetic drive is switched off, and peripheral resistance and blood pressure fall abruptly to low levels despite a burst of vasopressin release. Research in conscious animals has now shown that the onset of this decompensatory phase is triggered by a signal from the heart, which activates an endogenous opioid mechanism in the brain. Activation of this mechanism can be prevented by administering a selective (j..receptor antagonist, or selective f1-receptor agonists (including a/fentanil). It has not yet been established that this endogenous opioid mechanism is responsible for the decompensatory phase of acute blood loss in man, nor that it can be prevented or reversed by selective opioid agonists or antagonists.
pari passu with blood loss, but there were two distinct phases to the responses of other haemodynamic variables. Initially, heart rate and peripheral resistance increased progressively and blood pressure fell by only a few mmHg, but towards the end of the venesection in some of the volunteers there was an abrupt decrease in heart rate and peripheral resistance and a precipitate fall in blood pressure to -40 mmHg systolic. This profound hypotension was due entirely to the fall in peripheral resistance, since it was not accompanied by a further fall in cardiac output and it was not reversed by administering atropine. 2 Though no studies of this sort have been performed since that time, foot-down tilting or the application of suction to the lower half of the body (lower body negative pressure) have been used in man as surrogates for haemorrhage,4,5 and have provided some further information. For the most part, however, we have had to rely on experiments in laboratory animals to shed light on the mechanisms which are responsible for the maintenance of blood pressure during the first stage of acute blood loss, and for the decompensation that occurs subsequently. General anaesthesia has profound effects on reflex neurohumoral control of the circulation, so that only those experiments performed on unanaesthetised animals provide information which is relevant to humans who sustain acute blood loss outside the operating room. As a result of these experiments it has become clear that cardiac sensory receptors, endogenous opioid mechanisms, and certain neurohumoral factors make important contributions to the haemodynamic response to acute blood loss.
Regrettably, there is a dearth of serious research into the effects of anaesthesia in general, and of specific anaesthetic agents in particular, on the responses to acute hypovolaemia.
REFLEX CIRCULATORY COMPENSATION IN ACUTE BLOOD Loss
Aside from the remarkably rapid transfer of fluid from the extravascular space into the circulation, the maintenance of arterial pressure during acute blood loss is brought about by the engagement of cardiovascular reflexes. The most important of these are the arterial baroreceptor reflexes, but reflexes originating from receptors in the cardiopulmonary region (including receptors in some or all of the cardiac atria and ventricles, and the pulmonary vascular bed) may also contribute.
Arterial baroreceptor reflexes
The small reductions in mean arterial pressure and pulse pressure that occur when cardiac output begins to fall cause unloading of the arterial baroreceptors which are located in the carotid sinus (carotid baroreceptors), and in the aortic arch and brachiocephalic arteries (aortic baroreceptors). 6, 7 When this information is transmitted to the brain, it Anaesthesia and Intensive Care, Vol. /7, No. 3, August. 1989 evokes a reflex increase 10 sympathetic vasoconstrictor drive and the release of catecholamines from the adrenal medulla. Both these effector mechanisms are important in maintaining arterial pressure during acute blood loss in conscious animals. 8 In man, an acute reduction in central blood volume is accompanied by an increase in sympathetic drive 9 and in the plasma concentrations of catecholamines. 4 In unanaesthetised animals the vascular beds to which these effector mechanisms are directed by the arterial baroreflex include the splanchnic region, skeletal muscle, the kidney and, probably, the skin of the trunk and limbs. 10, 11 There is indirect evidence that baroreflex-mediated vasoconstriction occurs in the same vascular beds in man. 7 ,12 However, there is now evidence that the arterial baroreflexes do not constitute a barostat with a fixed set-point but operate on a sliding scaleY that is, the level at which the baroreflexes attempt to set blood pressure is readjusted within a matter of minutes in the direction in which blood pressure is moving. If downward resetting of the arterial baroreflexes were to occur in the course of acute blood loss (though this has not yet been established), it would be expected to render them progressively less effective in sustaining blood pressure.
Cardiopulmonary receptor reflexes
It has been supposed for many years that low-pressure baroreceptors in the heart and pulmonary vascular bed have the ability to sense a fall in central venous pressure, and to engage compensatory reflexes which sustain arterial blood pressure. 14 However, the evidence for this is somewhat tenuous. It relies very heavily on the demonstration that when lower body negative pressure is applied to humans, vasoconstriction occurs in the limbs and the splanchnic region before there is a fall in mean arterial pressure or pulse pressure (that is, before the arterial baroreflexes are engaged). 12 However, an important role for cardiac (if not pulmonary) receptors in acute blood loss has not been demonstrated in un anaesthetised animals under conditions in which the relative roles of arterial and cardiac baroreceptors can be clearly distinguished. 15 This discrepancy may reflect a species difference (for instance, the well-known Bainbridge reflex which originates in the atria appears to be almost exclusively expressed in dogs, and is weak or absent in primates and man),16 but the importance of cardiopulmonary receptor reflexes in the acute compensation for haemorrhage in man should be regarded as 'not proven'. Indeed, Rowell himself points out the paradox that receptors which sense changes in the low-pressure side of the circulation should regulate pressure within arteries. 12
FAILURE OF COMPENSATION IN ACUTE HYPOVOLAEMIA
Until very recently, laboratory studies of haemorrhage in un anaesthetised animals were concerned with the early, compensatory phase in which arterial pressure is well maintained. Only in the last five years or so has interest been rekindled in the abrupt decompensation which was so clearly demonstrated in man over 40 years ago. 2 ,3 In the interim it had been assumed that the cardiovascular reflexes continued to operate during continued blood loss, but became progressively less effective because of competition from local mechanisms in some of the peripheral vascular beds. 17 These peripheral vasodilator mechanisms have been called autoregulatory, since they tend to maintain regional blood flow constant in the face of changes in arterial pressure. They may be an important cause of circulatory decompensation during prolonged blood loss, but it is now clear that they are not responsible for the sudden fall in arterial pressure that occurs during acute blood loss.
The first hint that sympathetic drive itself might fail came from the observation that at the onset of postural syncope the sympathetic vasoconstrictor drive to skeletal muscle is suddenly switched off.9 This has recently been confirmed during studies in man of noradrenaline spillover, which is another measure of sympathetic drive. If syncope should occur by accident during the application of lower body negative pressure, noradrenaline spillover from organs such as the heart and kidneys drops to near zero (M. Esler, personal communication).
The sudden decompensation which was originally reported in man during acute haemorrhage has only recently been demonstrated in unanaesthetised rabbits and dogs. ls -2o When acute blood loss reaches about 30% of blood volume, or when venous return is dammed back so as to produce central hypovolaemia of a comparable magnitude,21 there is an abrupt fall in sympathetic neural drive. ls -24 The signal which triggers this event comes from cardiac receptors. 21 ,23 It is likely that these events are due to 'failure' of baroreflex-media ted circulatory compensation, since it is in the vascular beds that are under the control of the arterial baroreceptorslo,11 that vasoconstriction fails. IS There is also a reduction in heart rate, but the magnitude of this varies among species and it is never as dramatic as it is in man.
Holaday25 first proposed that endogenous opioid mechanisms have an important role in the regulation of the circulation. This hypothesis has only recently been put on a sound footing by well-controlled experiments in conscious animals. The evidence is as follows. Intravenous administration of naloxone, a 'broad-spectrum' but stereospecific opioid antagonist, will completely prevent the sudden decline of sympathetic drive, peripheral resistance and arterial pressure that otherwise occur during acute reduction of central blood volume;19,22 and it will restore sympathetic drive, peripheral resistance and blood pressure ifit is given after circulatory decompensation has occurred. ls ,26 Moreover, naloxone's preventive action is just as effective if it is given into the fourth ventricle of the brain, in doses that are up to lOOO-fold less than the corresponding intravenous dose. 24 This establishes that an endogenous opioid mechanism is responsible for the abrupt failure of baroreflex-mediated circulatory compensation, and that the mechanism resides in the central nervous system. However, one of the features of these actions of naloxone is that the intravenous dose required in animals is 3-5 mg/kg -several hundred times greater weight-for-weight than the dose that is necessary to reverse the effects of exogenous morphine in man. This led to the suspicion that naloxone, which is selective though not specific for the J.l . or morphinesensitive sub-type of opiate receptor, might in those circumstances be acting on another opiate receptor sub-type. This has now been confirmed, by the use of other antagonists that are selective for the different opiate receptor sub-types. The central nervous mechanism responsible for circulatory decompensation during acute hypovolaemia appears to be governed by the 0 sub-type of opiate receptor. 27 What triggers off this opiate receptormediated mechanism? In the 1940s Barcroft and his colleagues made the prophetic suggestion that it might be a signal from the empty heart which is responsible, and subsequent work on cardiac sensory afferents showed that this was indeed possible. 28 Confirmation of this hypothesis has now been provided by studies in which the cardiac afferent nerves were blocked by instilling procaine into the pericardial sac. This prevents both the failure of sympathetic vasoconstrictor drive,22 and the failure of peripheral resistance,24 that occur when acute blood loss is excessive. There are hints that the receptors responsible lie in the left ventricle, and fire off their signal as a result of the mechanical or metabolic consequences of impaired cardiac filling.
NEUROHUMORAL EFFECTOR MECHANISMS
There is also very new information about the effector mechanisms which sustain blood pressure during acute blood loss. There is no shortage of neural, humoral and local mechanisms that can affect the tone of vascular smooth muscle. The difficulty is to determine which ones actually come into play during acute blood loss, and to estimate their relative importance. The problem is compounded by the fact that the several vasoconstrictor and vasodilator mechanisms do not act independently of each other, but interact in a complex way that may alter with time or according to the magnitude of blood loss. The ideal design of experiments to sort this out is quite straightforward in principle: the response to haemorrhage should be measured after the various mechanisms have been taken out, singly and in every possible combination. It is not so simple to carry out these kinds of experiments in practice, but it has been done.
Anaesthesia and Intensive Care, Vol. 17, No. 3, August, 1989 It is clear that underlying all the observed changes in peripheral resistance during haemorrhage are local autoregulatory mechanisms which tend to maintain regional blood flow constant at the expense of blood pressure. This can be inferred from experiments in which either the afferent input from the principal cardiovascular receptors is abolished, 15,29 or in which most of the extrinsic effector mechanisms are knocked out (P. I. Korner, personal communication). In either case haemorrhage is then attended by a progressive fall in peripheral resistance, attributable to local autoregulatory dilator mechanisms. The cardiovascular reflexes, which are concerned with maintaining systemic blood pressure rather than regional blood flow, are superimposed on this background. It is known that sympathetic neural drive, and the secretions of the adrenal medulla, are important efferent pathways for these reflexes. But what of humoral agents such as arginine vasopressin (A VP) and angiotensin 11, both of which are powerful vasoconstrictors whose plasma concentrations rise during haemorrhage? It is now clear that A VP reaches vasoactive concentrations in the plasma only at the onset of the decompensatory phase of haemorrhage in conscious animals,30 or at the onset of postural syncope in humans. 4 ,31 Moreover, A VP release under these conditions (like activation of the endogenous opioid mechanism) depends on a signal from the heart, almost certainly from receptors in the left ventricle. 3o ,32 Plasma renin activity rises slowly almost from the outset of haemorrhage,30 but it is doubtful that angiotensin 11 reaches concentrations that are directly vasoconstrictor. 4 There is now more direct evidence that neither A VP nor angiotensin 11 plays an important part in compensatory vasoconstriction under normal conditions since the administration of specific antagonists has little effect on this phase of the response to haemorrhage. However, if the sympathoadrenal vasoconstrictor mechanisms are knocked out, there is an outpouring of A VP much earlier in haemorrhage, and it has an important effect in sustaining blood pressure (P. I. Korner, personal communication).
INTERACTIONS BETWEEN ANAESTHETIC AGENTS AND REFLEX HAEMODYNAMIC RESPONSES TO HAEMORRHAGE
We have set out above the evidence that the haemodynamic response to acute blood loss is biphasic, and that the decompensation which occurs when around 30% of blood volume is withdrawn is attributable to activation of an endogenous opioid mechanism within the brain. How, then, does general anaesthesia affect the response to acute blood loss? This question cannot be answered directly, since there appears to have been no study in which the haemodynamic effects of acute blood loss have been measured before and after the induction of anaesthesia.
Is there any information that might at least allow us to hypothesise how general anaesthesia -or, rather, individual anaesthetic agents -might alter the response to blood loss? For instance, we have seen that the early compensatory response depends on the integrity of the baroreflexes. Does general anaesthesia affect these? Astonishingly, there has been little work done that can give a meaningful answer even to this question.
. There is a large body of literature on the effects of anaesthetics on the baroreceptorheart rate reflex, much of it based on observations made in man. Yet most of the studies were done by injecting a bolus dose of a pressor drug such as phenylephrine and observing the subsequent reflex bradycardia. The. information that this sort of study provides is trivial, since it is now generally agreed that only when the full range of the baroreceptor-heart rate reflex is elicited can the effects of anaesthesia -or indeed of any other factor -be identified and interpreted. There have been a few studies of the effects of anaesthesia in animals (though none in man) in which the full range of the baroreceptorheart rate reflex has been characterised. From these it can be concluded that halothane,33 isoflurane,34 ketamine, thiopentone and althesin,35 and propofoP6 reduce the gain of the reflex, and the range of heart rate responses, in a dose-dependent fashion.
This information about the control of heart rate is not very useful, however, in the context of haemorrhage. Here the chief interest is in reflex control of resistance vessels and arterial pressure, and this is only poorly predicted by the reflex control of heart rate. 7 There has been a handful of studies in which the effects of anaesthetic agents on baroreflex control of blood pressure or peripheral resistance have been measured directly. In general, these show that the reflex control of blood pressure is relatively well preserved by comparison with heart rate. Nevertheless, ketamine,37 pentobarbitone,38 halothane 39 and isoflurane 4o all depress the baroreflex control of blood pressure in a dose-dependent fashion when this has been tested. There is a suggestion that althesin and thiopentone are less depressant. 37 On this basis one would expect that the haemodynamic compensation to blood loss would be blunted by most forms of general anaesthesia, but this remains an hypothesis since it has not been tested directly.
Finally, what about the effects of anaesthetics on the decompensatory phase of haemorrhage, which depends on cardiac receptors and an endogenous opiate mechanism? We have no information about how anaesthetics affect cardiac receptor reflexes. There is more than a suspicion, however, that anaesthetic agents interact with endogenous opioid mechanisms. This is obviously so in the case of opioid anaesthetics, but may also be true for agents such as halothane 41 and nitrous oxide. 42 We remain in ignorance, however, as to whether or how these putative interactions affect the responses to acute blood loss.
FUTURE DIRECTIONS
At the very least, the information that has come forward over the past five years about the haemodynamic responses to acute blood loss, and especially the roles of cardiac sensory receptors and of endogenous opioid mechanisms within the central nervous system, adds considerably to our understanding of what happens during haemorrhage and why ( Table 1) . Are there any practical applications of this knowledge?
Is there any evidence from clinical practice that the hypotension which results from severe blood loss has the same origins as it has in laboratory animals? The best evidence remains that of the World War 11 volunteers,2,3 in whom the abrupt fall of blood pressure was clearly due to failure of reflex vasoconstriction. Recently, a systematic study of patients who had lost one-third of their blood volume and were markedly hypotensive revealed that most had a relative bradycardia which was replaced by tachycardia when blood volume and blood pressure were restored. 43 We predict that future close observations on patients who have suffered acute blood loss will provide further confirmation that their haemodynamic patterns resemble those observed in conscious animals under laboratory conditions. If a person sustains acute blood loss which is life-threatening, the logical treatment is to re-expand the blood volume by transfusion or infusion. In some circumstances -for instance, under battlefield conditions or the civilian equivalent on the highways -this is not immediately possible. Is there then a case for administering an opioid antagonist? It would be inappropriate, on two counts, to recommend the administration of naloxone. First, there have been no clinical observations that show it to be effective -though in the studies that have been done the dose used was far below that which has a pressor action in laboratory animals. 44 Moreover, when effective doses of naloxone are given to rats as the sole treatment for severe blood loss, it is doubtful that their chances of survival are improved. 45 The second objection to using naloxone in clinical practice is that its action as a ll-receptor antagonist would abolish the effects of narcotic analgesics. However, a new twist has been given by the evidence that it is a 8-receptor mechanism which is responsible for circulatory decompensation during acute blood loss. Could a 8-specific antagonist be used therapeutically? Its action would be quite different from that of direct-acting vasoconstrictors since it does not raise peripheral resistance unless there is central hypovolaemia and an input from cardiac receptors. That is, it would cease to have an action once blood volume had been restored. The selective 8-antagonists that have been available are peptides that do not cross the blood-brain barrier. A non-peptide selective 8-antagonist has very recently been developed,46 but its efficacy in preventing circulatory decompensation has not yet been tested.
We have recently observed in our laboratory that large doses of specific 11-and J(receptor agonists will also prevent circulatory decompensation if injected into the fourth ventricle of unanaesthetised rabbits, as will intravenous infusion of the ll-receptor anaesthetic agent alfentanil (unpublished observations). Much more work needs to be done to elucidate the mechanisms that underlie these phenomena, but it may turn out that conventional doses of morphine have the same effect.
The third direction in which work needs to be done is on the in~eraction between anaesthetic agents and blood loss. Our current knowledge allows no recommendation to be made about the most appropriate anaesthetic agent to use when unreplaced blood loss has occurred, or when blood loss during anaesthesia is anticipated. This practical problem provides a fruitful field for future research.
